Management of Osteoarthritis and Chronic Pain: Where Are We Now?
Industry Webcast Sponsored by Pfizer and Eli Lilly and Company; Not for CME/CE Credit
This presentation will provide an overview of the epidemiology and treatment of osteoarthritis (OA) and chronic OA pain. We will review the current understanding of chronic pain pathophysiology – the various mediators, their role in central and peripheral sensitization, and the nociceptive components of chronic OA pain. We will also examine current OA treatment guidelines and explore “multimodal” treatment options, with a focus on working with patients toward individual treatment goals, and the establishment of holistic management strategies for patients with chronic OA pain.
This content is developed exclusively by or on behalf of the industry sponsor; it is not reviewed or associated with Pri-Med and Pri-Med does not endorse or sanction any third-party content.
• Discuss the epidemiology, disease burden, and unmet needs in osteoarthritis and chronic osteoarthritis pain
• Explore the role of peripheral and central sensitization in the development of chronic pain and the key mediators involved
• Review current treatment approaches and recent clinical guidelines on improving comprehensive multidisciplinary care in osteoarthritis
• Identify strategies for holistic management of patients with chronic osteoarthritis pain